Chris Evert has joined forces with Regener-Eyes to spread awareness of their first-in-class biologic eye drop. Regener-Eyes is an ophthalmic solution that aids in supporting eye lubrication for people experiencing eye discomfort or irritation. Evert views her partnership with Regener-Eyes as an opportunity to help athletes of all ages understand the benefits of this ophthalmic solution.

“I’m very excited to join the Regener-Eyes team,” said Evert. “I appreciate the power of community and the ability to bring an ophthalmic solution that so many people within my audience may find useful and life-enhancing.”

Discomfort and eye irritation can be common for athletes. Regener-Eyes provides the ease they need to continue to practice and play the sports they love. “Partnering with the world’s former No. 1 tennis player made complete sense for Regener-Eyes, as she has a captive audience of athletes and baby boomers that understand the need for lubrication and comfort for the eyes, while practicing a sport,” said Heidi Hart Pukas, Sr. Vice President of Marketing and Corporate Communications.

Founder and CEO C. Randall Harrell, M.D., researched dry eye disease (DED) caused by meibomian gland dysfunction (MGD) after watching his mother suffer from Mixed Connective Tissue Disease for years. Realizing how common dry eye disease is—340 million people worldwide suffer from dry eyes—he decided to study a newer generation of medicine: regenerative medicine.